Endothelial Dysfunction: Clinical Trials

6 trials for Endothelial Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Recruiting 6
Phase 23Recruiting 3

Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
TB-500, Placebo - Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
Phase 1 / Phase 2RecruitingHudson Biotech802026-02-052026-11-12
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain
Phase 1 / Phase 2RecruitingUniversity of Calgary122023-01-012026-05-01
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
EO2002, Ripasudil - Corneal Edema, Corneal Endothelial Dystrophy
Phase 1RecruitingAsociación para Evitar la Ceguera en México122022-11-082025-12-08
B-Complex: A Nutraceutical SANS Countermeasure
Vitamin B-Complex Supplement - Optic Disc Edema, Endothelial Dysfunction
Phase 1RecruitingNational Aeronautics and Space Administration (NASA)162022-08-012026-11-12
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
Metformin Hcl 1000Mg Tab, Aminohippurate Sodium 20 % Injection, Iohexol 300 Mg/mL Injectable Solution - Type 1 Diabetes, Diabetic Kidney Disease
Phase 1RecruitingKalie Tommerdahl602022-07-012025-06-13
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
Galantamine, Placebo, TENS 7000 - Endothelial Dysfunction
Phase 1 / Phase 2RecruitingVanderbilt University Medical Center1602021-12-202026-05-18

Narrower conditions

Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Corneal Dystrophy, Posterior Polymorphous, 1 (1)  ·  Corneal Edema (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetic Nephropathies (1)  ·  Fuchs' Endothelial Dystrophy (1)  ·  Hypoxia, Brain (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Papilledema (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Wake Disorders (1)  ·  Stroke (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Eye Diseases (2)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Apnea (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Autoimmune Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Corneal Diseases (1)  ·  Corneal Dystrophies, Hereditary (1)

Interventions

Cerebrovascular Circulation (1)  ·  Core Binding Factors (1)  ·  Galantamine (1)  ·  Injections (1)  ·  Iohexol (1)  ·  K-115 (1)  ·  Metformin (1)  ·  Sugars (1)  ·  p-Aminohippuric Acid (1)

Sponsors

Asociación para Evitar la Ceguera en México (1)  ·  Hudson Biotech (1)  ·  Kalie Tommerdahl (1)  ·  National Aeronautics and Space Administration (NASA) (1)  ·  University of Calgary (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)  ·  Mexico (1)

Top investigators

Cyndya Shibao, MD (1)  ·  Sara R Zwart, PhD (1)  ·  Valeria Sanchez Huerta, MD (1)

NIH funding

K23HL159292 (1)